Terapias Avanzadas para Tumores Sólidos Pediátricos
The Bristol-Myers Squibb Children's Hospital
Nuevo Brunswick, Estados UnidosPublicaciones en colaboración con investigadores/as de The Bristol-Myers Squibb Children's Hospital (5)
2020
-
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Immunity, Vol. 52, Núm. 5, pp. 856-871.e8
2018
-
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes
Cancer Immunology Research, Vol. 6, Núm. 1, pp. 69-78
-
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)
OncoImmunology, Vol. 7, Núm. 1
2016
-
Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming
Cancer Research, Vol. 76, Núm. 20, pp. 5994-6005
-
Cancer immunotherapy with immunomodulatory anti-CD137 and anti–PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells
Cancer Discovery, Vol. 6, Núm. 1, pp. 71-79